Cargando…
Hypothesis-Driven, Structure-Based Design in Photopharmacology: The Case of eDHFR Inhibitors
[Image: see text] Photopharmacology uses light to regulate the biological activity of drugs. This precise control is obtained through the incorporation of molecular photoswitches into bioactive molecules. A major challenge for photopharmacology is the rational design of photoswitchable drugs that sh...
Autores principales: | Kobauri, Piermichele, Galenkamp, Nicole S., Schulte, Albert M., de Vries, Jisk, Simeth, Nadja A., Maglia, Giovanni, Thallmair, Sebastian, Kolarski, Dušan, Szymanski, Wiktor, Feringa, Ben L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958501/ https://www.ncbi.nlm.nih.gov/pubmed/35258959 http://dx.doi.org/10.1021/acs.jmedchem.1c01962 |
Ejemplares similares
-
Photopharmacological
Manipulation of Mammalian CRY1
for Regulation of the Circadian Clock
por: Kolarski, Dušan, et al.
Publicado: (2021) -
Regulation of eDHFR-tagged proteins with trimethoprim PROTACs
por: Etersque, Jean M., et al.
Publicado: (2023) -
Light-Control over Casein Kinase 1δ Activity with Photopharmacology: A Clear Case for Arylazopyrazole-Based Inhibitors
por: Schulte, Albert M., et al.
Publicado: (2022) -
Rational design of a photoswitchable DNA glue enabling high regulatory function and supramolecular chirality transfer
por: Simeth, Nadja A., et al.
Publicado: (2021) -
Mechanism of Resistance Development in E. coli against TCAT, a Trimethoprim-Based Photoswitchable Antibiotic
por: Lauxen, Anna I., et al.
Publicado: (2021)